|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 Massachusetts Avenue, NW |
Address2 | Suite 610 |
City | Washington |
State | DC |
Zip Code | 20001-1430 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Rolling Meadows |
State | IL |
Zip Code | 60008 |
Country | USA |
|
5. Senate ID# 1648-12
|
||||||||
|
6. House ID# 338710000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: KATHERINE O. ORRICO |
Date | 10/20/2020 10:33:25 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 348, Resident Physician Shortage Reduction Act, to provide Medicare funding for additional residency training slots
H.R. 1763, Resident Physician Shortage Reduction Act, to provide Medicare funding for additional residency training slots
H.R.3107, Improving Seniors Timely Access to Care Act, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes
H.R. 8505, to waive Medicare's budget neutrality requirements when new office visit code values are implemented in 2021
No bill: Legislation to prevent Medicare cuts
No bill: COVID-19 relief, including additional financial support for physician practices, medical liability protections, suspending Medicares budget neutrality requirements, enhanced telemedicine, prior authorization relief
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S.1531, STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing
S. 4317, the Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act: COVID-19-related medical liability protections.
H.R.5826, Consumer Protections Against Surprise Medical Bills Act, to provide protections for health insurance consumers from surprise billing
H.R.7059, Coronavirus Provider Protection Act: COVID-19-related medical liability protections
No bill: Compromise legislation to provide protections for health insurance consumers from surprise medical bills
No bill: COVID-19 relief, including additional financial support for physician practices, medical liability protections, suspending Medicares budget neutrality requirements, enhanced telemedicine, prior authorization relief
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act: extending Medicares geographic practice cost index increases for rural physicians; delaying cuts to Medicaid disproportionate share hospitals; and extending the Medicare advanced and accelerated payment program loan repayment deadline to one year and lowering the interest rate for COVID-19 provider relief funds
No bill: COVID-19 relief, including additional financial support for physician practices, medical liability protections, suspending Medicares budget neutrality requirements, enhanced telemedicine, prior authorization relief
No bill: Funding for the Military and Civilian Partnership for the Trauma Readiness Grant Program
No bill: Funding for the Pediatric Subspecialty Loan Repayment Program
No bill: Funding for the National Concussion Surveillance System
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 4525, Eliminating the Provider Relief Fund Tax Penalties Act: making provider relief funds non-taxable
H.R. 7819, Eliminating the Provider Relief Fund Tax Penalties Act: making provider relief funds non-taxable
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Mortimer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |